Menu
GWAS Study

Genome-wide association analysis identifies a susceptibility locus for sporadic vestibular schwannoma at 9p21.

Sadler KV, Bowes J, Rowlands CF et al.

36546557 PubMed ID
GWAS Study Type
6411 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SK
Sadler KV
BJ
Bowes J
RC
Rowlands CF
PC
Perez-Becerril C
VD
van der Meer CM
KA
King AT
RS
Rutherford SA
PO
Pathmanaban ON
HC
Hammerbeck-Ward C
LS
Lloyd SKW
FS
Freeman SR
WR
Williams R
HC
Hannan CJ
LD
Lewis D
ES
Eyre S
ED
Evans DG
SM
Smith MJ
Chapter II

Abstract

Summary of the research findings

Vestibular schwannomas are benign nerve sheath tumours that arise on the vestibulocochlear nerves. Vestibular schwannomas are known to occur in the context of tumour predisposition syndromes NF2-related and LZTR1-related schwannomatosis. However, the majority of vestibular schwannomas present sporadically without identification of germline pathogenic variants. To identify novel genetic associations with risk of vestibular schwannoma development, we conducted a genome-wide association study in a cohort of 911 sporadic vestibular schwannoma cases collated from the neurofibromatosis type 2 genetic testing service in the north-west of England, UK and 5500 control samples from the UK Biobank resource. One risk locus reached genome-wide significance in our association analysis (9p21.3, rs1556516, P = 1.47 × 10-13, odds ratio = 0.67, allele frequency = 0.52). 9p21.3 is a genome-wide association study association hotspot, and a number of genes are localized to this region, notably CDKN2B-AS1 and CDKN2A/B, also referred to as the INK4 locus. Dysregulation of gene products within the INK4 locus have been associated with multiple pathologies and the genes in this region have been observed to directly impact the expression of one another. Recurrent associations of the INK4 locus with components of well-described oncogenic pathways provides compelling evidence that the 9p21.3 region is truly associated with risk of vestibular schwannoma tumorigenesis.

911 British ancestry cases, 5,500 British ancestry controls

Chapter III

Study Statistics

Key metrics and study information

6411
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.